Showing 2621-2630 of 5621 results for "".
- EyePoint Pharmaceuticals Presents Data Showcasing Dexycu at the ASCRS Virtual Meetinghttps://modernod.com/news/eyepoint-pharmaceuticals-presents-data-showcasing-dexycu-at-the-ascrs-virtual-meeting/2477784/EyePoint Pharmaceuticals announced the presentation of positive retrospective case study data supporting Dexycu (dexamethasone intraocular suspension) 9% for the treatment of postoperative inflammation following ocular surgery. The data were presented in three electronic posters and one oral pape
- VSY Biotechnology Says It Has Developed a New Drug to Treat COVID-19https://modernod.com/news/vsy-biotechnology-says-it-has-developed-a-new-drug-to-treat-covid-19/2477774/Ophthalmic company VSY Biotechnology announced that its research center has developed a new drug, TR-C 19, to treat COVID-19. Studies have shown that TR-C 19 can neutralize the virus isolated under laboratory conditions, according to a company news release. The drug is now at the authority
- House Democrats Push New Round of Stimulus Checks in Coronavirus Billhttps://modernod.com/news/house-democrats-push-new-round-of-stimulus-checks-in-coronavirus-bill/2477760/House Democratic leaders are pushing for another round of stimulus payments of up to $1,200 per person in new coronavirus relief legislation that’s headed for a vote Friday, according to an NBC News report.
- VisionCare Announces CE Mark Approval of the Tsert-SI Delivery System for the CentraSight Treatment Programhttps://modernod.com/news/visioncare-announces-ce-mark-approval-of-the-tsert-si-delivery-system-for-the-centrasight-treatment-program/2477744/VisionCare has received CE Mark for the Tsert-SI delivery system for the CentraSight treatment program, which includes the Implantable Miniature Telescope (by Dr. Isaac Lipshitz). The Tsert-SI delivery system includes a pre-loaded telescope implant injector, which only requires a 6.5mm incision,
- Dyno Therapeutics Collaborates With Novartis to Develop Improved Gene Therapies With AAV Vectors Based on AI Technologyhttps://modernod.com/news/dyno-therapeutics-collaborates-with-novartis-to-develop-improved-gene-therapies-with-aav-vectors-based-on-ai-technology/2477740/Dyno Therapeutics announced a collaboration with Novartis to develop improved adeno-associated virus (AAV) vectors for research, development, and commercialization of gene therapies for ocular diseases. Financial terms of the deal were not disclosed. The partnership will allow the p
- Visual Impairment Tied to Increased Dementia Risk in Older Womenhttps://modernod.com/news/visual-impairment-tied-to-increased-dementia-risk-in-older-women/2477730/Older women with objective visual impairment are likely to develop dementia or mild cognitive impairment, a secondary analysis of data from the Women’s Health Initiative (WHI) suggests, according to a Reuters report. Researche
- UK Surpasses Italy In Recorded Coronavirus Deaths, Now Leads Europe In Fatalitieshttps://modernod.com/news/uk-surpasses-italy-in-recorded-coronavirus-deaths-now-leads-europe-in-fatalities/2477715/Over 32,000 people have died from the new coronavirus in the United Kingdom, according to the Office for National Statistics, marking the first time in the pandemic that it has led Europe in the number of deaths, according to an NPR
- AbbVie, Allergan Gain US Antitrust Clearance for Dealhttps://modernod.com/news/abbvie-allergan-gain-us-antitrust-clearance-for-deal/2477714/The US Federal Trade Commission (FTC) accepted the proposed consent order in connection with AbbVie’s pending $63-billion acquisition of Allergan, the companies announced. The FTC’s decision means that all required antitrust clearances needed for the merger have now been obtained.
- AI-Supported Test Can Detect Glaucoma Progression 18 Months Earlierhttps://modernod.com/news/ai-supported-test-can-detect-glaucoma-progression-18-months-earlier/2477706/A new test can detect glaucoma progression 18 months earlier than the current gold standard method, according to results from a clinical trial sponsored by the University College London (UCL). The technology, supported by an artificial intelligence (AI) algorithm, could help accelerate cli
- Studies Yield Mixed Findings for Investigational Drug Abicipar in Wet AMDhttps://modernod.com/news/studies-yield-mixed-findings-for-investigational-drug-abicipar-in-wet-amd/2477703/The investigational drug abicipar pegol is noninferior to ranibizumab for achieving stable vision in people with wet age-related macular degeneration (AMD), according to a pair of phase-3 trials, as reported by Reuters.wet Abicipar